| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |